Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published on August 11
Engine Capital's activist push for an Avantor sale could trigger a domino effect of acquisitions across the life sciences sector. Companies in this space may see increased investor interest and potential takeover bids.
If Avantor gets acquired, competitors could capture significant market share and attract new customers. This disruption creates potential value for rival suppliers positioned to benefit from the shake-up.
These stocks were carefully selected as key competitors and potential acquisition targets that could benefit from sector consolidation. Professional analysts identified these companies as positioned to gain from the current industry dynamics.
Activist investor Engine Capital's push for an Avantor sale could trigger a wave of consolidation across the life sciences supply sector. This event-driven opportunity focuses on companies that provide essential tools and services to biotechnology and pharmaceutical research, positioning investors to benefit from potential industry revaluation and M&A activity.
This group comprises life sciences suppliers and service providers that could benefit from sector disruption. These companies operate in a specialised market serving biotech, pharmaceutical, and diagnostic research. The potential for increased M&A activity makes this a tactical, event-driven investment theme with both opportunities and risks.
These stocks were handpicked as key competitors and potential takeover targets that could benefit from the Avantor situation. They represent companies positioned to gain market share from disruption or become attractive acquisition targets themselves, offering exposure to the life sciences value chain during this period of potential consolidation.
Market-cap breakdown for the 'Activist Sparks Life Science Shakeup' basket highlighting total capitalisation and constituent sizes.
TMO: $210.70B
DHR: $155.94B
ILMN: $15.21B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
BHP Group recently posted a massive earnings beat driven by record copper profitability, allowing the miner to raise its dividend to a four-year high. This performance highlights a structural shift toward electrification metals, creating opportunities for industrial equipment suppliers and competing copper producers.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+51.62%
On average, analysts expect assets in this group to grow 51.62% over the next year.
13 of 14 assets in this group are rated Buy by professional analysts.
